4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001628280-16-021746
CIK 0001600132operating
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 10:40 AM ET
Size
6.8 KB
Accession
0001628280-16-021746
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Purchase
Common Stock
2016-11-29+142,857→ 142,857 total - Purchase
Common Stock Warrants (right to buy)
2016-11-29+142,857→ 142,857 totalExercise: $0.80From: 2016-11-29Exp: 2021-11-29→ Common Stock (142,857 underlying)
Footnotes (1)
- [F1]The reported securities are included within 142,857 Class A Units purchased by the reporting person for $0.70 per Class A Unit. Each Class A Unit consists of one share of common stock and one warrant to purchase one share of common stock.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 10:40 AM ET
- Size
- 6.8 KB